2 ms·
Are you located anywhere near the University of Texas? There appears to be a protocol combining etigilimab and nivolumab. https://www.cancer.gov/research/parti
by toomuchtodo 2y ago
Are you located anywhere near the University of Texas? There appears to be a protocol combining etigilimab and nivolumab.
https://www.cancer.gov/research/participate/clinical-trials-search/v?id=NCI-2021-08531 https://www.cancer.gov/research/participate/clinical-trials-...
https://www.mdanderson.org/cancerwise/ovarian-cancer-survivor--an-immunotherapy-clinical-trial-saved-my-life.h00-159618645.html https://www.mdanderson.org/cancerwise/ovarian-cancer-survivo...
Another potential protocol involves azenosertib in patients with high-grade serous ovarian, fallopian tube, or primary peritoneal cancer.
https://www.onclive.com/view/dr-westin-on-early-findings-with-azenosertib-in-high-grade-serous-ovarian-cancer https://www.onclive.com/view/dr-westin-on-early-findings-wit...
(not a doctor, not medical advice, just connecting dots, please take citations to a highly competent practitioner in this specific medicine domain such as the oncologist care provider/team of the patient you are advocating for, this is simply due diligence to prevent potential blindspots, we are all just human)